clinical trial · NCT05934942
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
Boehringer Ingelheim·phase1·terminated·n = 29
HealthyYasmin®BI 1358894
brief summary
This study aims to investigate the effect of multiple doses of BI 1358894 on pharmacokinetics of ethinylestradiol (EE) and drospirenone (DRSP) (Yasmin®)
started
Sep 8, 2023
primary completion
Feb 8, 2024
completion
Feb 8, 2024
last updated
Feb 24, 2025
official title
An Open-label, Fixed-sequence Cross-over, Two-period, Phase I Trial to Evaluate the Effect of Multiple Doses of BI 1358894 on the Pharmacokinetics of a Combination of Ethinylestradiol and Drospirenone in Healthy Female Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol